Westermark sign describes regional pulmonary oligaemia on chest radiography distal to pulmonary arterial obstruction by an embolus. The affected region appears relatively hyperlucent, with attenuation or absence of peripheral pulmonary vascular markings and sometimes abrupt termination of the normally visible central vessels as they enter the hypoperfused lung.

The appearance primarily reflects reduced pulmonary arterial perfusion distal to the embolic obstruction, potentially accentuated by peripheral pulmonary arterial vasoconstriction. The extent may range from a segmental or wedge-shaped region to an entire lobe or lung, depending on the level and extent of vascular obstruction.

Westermark sign is uncommon and has low sensitivity for acute pulmonary embolism. When present in an appropriate clinical setting it is a useful radiographic clue, but its absence does not exclude PE and definitive diagnosis requires appropriate vascular imaging.

Westermark sign may raise suspicion for PE when present, but its absence has little exclusionary value.

westermark sign oligemia pulmonary embolus
Westermark sign: relative oligemia in right sided pulmonary embolus. Hampton hump is also visible

Historical development

1938Nils Westermark published On the roentgen diagnosis of lung embolism. Since 1933 he had examined 26 patients radiographically in whom pulmonary arterial embolism was demonstrated at autopsy. All had been radiographed within two weeks of death, many repeatedly. Four were imaged on the day of death and eight within two days.

Of these 26 patients, 10 showed pulmonary infarction, while the remaining 16 demonstrated embolism without infarction. Importantly, in seven of the ten infarction cases the radiographic evidence of embolic vascular obstruction involved a larger territory than the infarct itself. Westermark then studied a further 18 clinical cases, comparing radiographs during the embolic episode with films obtained during healing and recovery.

Westermark Case 2, Case 3 1938
Westermark sign. Left (Figure 3): marked right-sided pulmonary oligaemia, most pronounced in the upper lobe, with abrupt termination of the central vascular markings. Right (Figure 6): wedge-shaped right lower-lobe hyperlucency with absent peripheral vascular markings and abrupt central vascular cutoff following acute pulmonary embolism. Westermark, 1938.

In embolism without infarction, the pulmonary arterial branches distal to the embolus were depleted of blood and contracted. The corresponding lung remained aerated, producing a localised area of increased lucency with attenuated or absent vascular markings. The central vessels remained visible but could terminate abruptly as they reached the oligaemic territory.

In embolism of the pulmonary artery without infarction we get ischaemia of the branches of the pulmonary artery on the peripheral side of the embolus. On the radiogram this ischaemia appears as a clarified area with diminished vascular design corresponding to the extent of the embolised artery. The vascularisation is however maintained in the central parts of the lung. The vascularisation takes however a rapid end to pass over into the above mentioned area of non-vascularisation.

Westermark 1938

1951 – Hanelin and Eyler published Pulmonary Artery Thrombosis: Roentgen Manifestations reviewing five cases involving the main pulmonary artery or major branches. They credited Westermark with describing decreased peripheral vessel visibility and increased radiolucency, together with enlargement and apparent abrupt termination of major vascular shadows.

1977 – Bedard and Bone published Westermark’s sign in the diagnosis of pulmonary emboli in patients with the adult respiratory distress syndrome. They described two patients with ARDS in whom development of localised hyperlucency against otherwise diffuse pulmonary infiltrates prompted recognition of superimposed PE, subsequently confirmed by pulmonary arteriography.

1993 – Worsley et al., analysing the PIOPED cohort, prospectively evaluated the classic CXR findings of acute PE. Westermark sign proved relatively specific but poorly sensitive, with reported values of approximately 14% sensitivity and 92% specificity.

2007Sreenivasan, Bennett and Parfitt published a modern correlation. CXR demonstrated focal right-sided oligaemia together with Palla sign, while perfusion scintigraphy showed a corresponding large perfusion defect in the same region.

2014Abbas et al. demonstrated Westermark and Palla signs on CXR with CTPA showing subtotal right main pulmonary arterial occlusion and marked relative oligaemia of the right upper and middle lobes.

2020 – Al Dandan et al. published Clinical and imaging profiles of pulmonary embolism. Among 83 patients with PE who had a chest radiograph, only 2 (2.4%) demonstrated Westermark sign. The study contains only confirmed PE cases and cannot estimate specificity, but reinforces how rarely the sign is encountered in contemporary practice.


Eponymythology

Westermark did not describe a “Westermark sign”. His 1938 paper described a clarified area with diminished vascular design caused by pulmonary arterial embolism without infarction. The eponymous term was applied subsequently.

Modern descriptions often define Westermark sign simply as unilateral or regional hyperlucency. Westermark’s original description was more specific “reduced or absent peripheral vascular markings corresponding to an embolised arterial territory, with preservation and abrupt termination of central vessels“. Hyperlucency was therefore the consequence of regional vascular depletion, not the defining observation in isolation.


Associated Persons

Alternative names
  • Relative oligemia

Related signs: Westermark sign represents the distal hypoperfused vascular territory. Fleischner and Palla signs describe proximal pulmonary arterial enlargement, while the knuckle sign describes abrupt arterial cutoff. Hampton hump represents the separate parenchymal consequence of pulmonary infarction.


References

Original articles

Review articles

eponymictionary

the names behind the name

Dr David Yu MD LITFL author Squiggler
David Yu, M.D., Ph.D. Full time anesthesiologist in the department of Perioperative medicine and Intensive Care (PMI), Karolinska University Hospital, Sweden. Dual board certified in internal medicine, and anesthesiology and critical care. Clinical interests are the critically ill patient, hemodynamic cases, perioperative echocardiography and procedural awareness, and of course all things ECG! | Squiggler |

BA MA (Oxon) MBChB (Edin) FACEM FFSEM. Emergency physician, Sir Charles Gairdner Hospital. Passion for rugby, medical history, medical education, and asynchronous learning #FOAMed evangelist. Co-founder and CTO of Life in the Fast lane | On Call: Principles and Protocols 4e| Eponyms | Books | Horology

2 Comments

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.